In the last trading session, 0.16 million shares of the Quantum BioPharma Ltd (NASDAQ:QNTM) were traded, and its beta was 0.39. Most recently the company’s share price was $11.55, and it changed around -$0.67 or -5.48% from the last close, which brings the market valuation of the company to $33.61M. QNTM currently trades at a discount to its 52-week high of $24.76, offering almost -114.37% off that amount. The share price’s 52-week low was $2.70, which indicates that the current value has risen by an impressive 76.62% since then.

Quantum BioPharma Ltd stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended QNTM as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.

Quantum BioPharma Ltd (NASDAQ:QNTM) trade information

Instantly QNTM has showed a red trend with a performance of -5.48% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 13.44 on recent trading dayincreased the stock’s daily price by 14.06%. The company’s shares are currently up 213.86% year-to-date, but still up 12.68% over the last five days. On the other hand, Quantum BioPharma Ltd (NASDAQ:QNTM) is 67.15% up in the 30-day period.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 48.95%.

QNTM Dividends

Quantum BioPharma Ltd’s next quarterly earnings report is expected to be released in June.

The former held 66.99 shares worth $0.77 million, making up 2.30% of all outstanding shares.